Rod Wong: Stock Portfolio, Performance and Latest Trades
RTW Investments
13F portfolio value
$11.7B
84 holdings at Q2 2026
Get an email when Rod Wong files a new 13F report
Free, no account needed. Unsubscribe with one click.
Rod Wong's portfolio
As of Q2 2026, filed August 14, 2026 · prices as of October 8, 2026
| Company | Share of portfolio | Average buy price | Return | Current price | Last quarter |
|---|---|---|---|---|---|
| 9.14% | $231.65 | +106% | $476.91 | No change | |
Argenx SE - ADRARGX | 5.62% | $374.36 | +119% | $818.63 | No change |
| 5.39% | $38.69 | +61.7% | $62.56 | No change | |
| 5.30% | $23.88 | +486% | $139.91 | Added +0.0% | |
CG Oncology Inc.CGON | 5.16% | $53.55 | +18.1% | $63.26 | Added +22% |
Insmed Inc.INSM | 4.41% | $94.32 | +6.5% | $100.48 | No change |
| 3.71% | $13.82 | +63.4% | $22.57 | Added +4.5% | |
| 3.22% | $22.63 | +253% | $79.90 | Added +1.9% | |
Celcuity Inc.CELC | 2.95% | $105.08 | −35.4% | $67.87 | Added +8.7% |
Erasca Inc.ERAS | 2.81% | $12.39 | +24.7% | $15.46 | Added +11% |
Radnet Inc.RDNT | 2.55% | $56.22 | +21.3% | $68.21 | Added +13% |
| 2.55% | $45.19 | +71.0% | $77.28 | Added +53% | |
Natera Inc.NTRA | 2.32% | $42.81 | +813% | $390.79 | Reduced −20% |
| 2.22% | $30.77 | −50.3% | $15.29 | Added +114% | |
| 2.22% | $155.51 | −34.0% | $102.60 | Added +31% | |
| 2.08% | $31.34 | +97.9% | $62.01 | Added +5.2% | |
| 2.03% | $21.98 | −54.5% | $10.00 | New | |
| 1.95% | $28.75 | +111% | $60.61 | No change | |
| 1.90% | $48.77 | +239% | $165.56 | No change | |
| 1.82% | $120.15 | +17.6% | $141.25 | Added +19% | |
| 1.80% | $28.50 | +153% | $72.22 | Added +0.3% | |
| 1.57% | $24.22 | −1.1% | $23.95 | No change | |
Uniqure NVQURE | 1.55% | $25.38 | −11.2% | $22.54 | Added +52% |
| 1.54% | $21.24 | −7.8% | $19.58 | No change | |
Repligen Corp.RGEN | 1.45% | $153.75 | +6.6% | $163.84 | Added +2.9% |
| 1.43% | $14.93 | +148% | $36.98 | No change | |
GH Research PLCGHRS | 1.36% | $15.27 | +33.9% | $20.45 | No change |
| 1.32% | $41.85 | −30.5% | $29.09 | No change | |
| 1.29% | $4.52 | +154% | $11.47 | Added +0.6% | |
Immatics NVIMTX | 1.12% | $10.00 | −26.3% | $7.37 | Added +0.6% |
Zai Lab Ltd-AdrZLAB | 1.07% | $25.69 | −3.4% | $24.81 | No change |
Immunovant Inc.IMVT | 1.05% | $22.30 | +35.7% | $30.26 | No change |
| 0.94% | $95.37 | +59.9% | $152.52 | No change | |
Xencor Inc.XNCR | 0.93% | $13.91 | +76.2% | $24.50 | No change |
| 0.79% | $2.28 | +94.5% | $4.43 | Reduced −0.9% | |
| 0.76% | $24.71 | +21.7% | $30.08 | Reduced −58% | |
Alkermes PLCALKS | 0.75% | $27.15 | +47.7% | $40.11 | No change |
| 0.74% | $44.24 | −42.0% | $25.67 | New | |
| 0.70% | $6.32 | +106% | $13.04 | Added +0.7% | |
| 0.57% | $32.29 | +4.4% | $33.71 | Added +0.7% | |
| 0.56% | $5.44 | +77.5% | $9.66 | No change | |
| 0.52% | $17.00 | −84.5% | $2.63 | No change | |
| 0.49% | $20.48 | +360% | $94.26 | No change | |
| 0.44% | $19.42 | −8.6% | $17.74 | No change | |
Axogen Inc.AXGN | 0.40% | $40.32 | −10.3% | $36.18 | New |
| 0.37% | $181.57 | +19.8% | $217.46 | New | |
| 0.37% | $18.52 | −16.5% | $15.46 | Added +39% | |
Neurogene Inc.NGNE | 0.37% | $32.23 | −17.8% | $26.50 | No change |
| 0.35% | $42.77 | +129% | $98.00 | Reduced −74% | |
| 0.35% | $9.33 | −38.6% | $5.73 | Added +15% | |
| 0.33% | $7.58 | −10.0% | $6.82 | New | |
Savara Inc.SVRA | 0.31% | $4.90 | −1.4% | $4.83 | No change |
| 0.26% | $4.28 | +11.2% | $4.76 | No change | |
| 0.23% | $67.53 | +61.9% | $109.30 | No change | |
Verastem Inc.VSTM | 0.22% | $6.82 | +18.9% | $8.11 | Added +0.9% |
| 0.21% | $57.91 | +42.3% | $82.43 | No change | |
| 0.20% | $18.64 | −6.5% | $17.43 | Reduced −25% | |
| 0.18% | $2.10 | −30.6% | $1.46 | No change | |
Evommune Inc.EVMN | 0.17% | $19.40 | −67.0% | $6.41 | No change |
| 0.17% | $25.51 | −3.6% | $24.60 | No change | |
| 0.16% | $18.91 | +80.8% | $34.18 | Added +33% | |
| 0.12% | $30.61 | +17.8% | $36.06 | New | |
Ataibeckley Inc.04650F101 | 0.09% | $3.54 | — | — | No change |
| 0.09% | $7.17 | −90.1% | $0.712 | Added +24% | |
Ocugen Inc.OCGN | 0.09% | $1.73 | −43.5% | $0.977 | No change |
| 0.09% | $9.39 | — | — | Added +88% | |
Heartflow Inc.HTFL | 0.07% | $32.24 | +47.7% | $47.63 | Reduced −40% |
Freenome Inc.FRNM | 0.07% | $10.06 | +57.2% | $15.81 | No change |
Wave Life Sciences Ltd.Y95308105 | 0.07% | $11.13 | — | — | No change |
| 0.07% | $3.84 | −29.7% | $2.70 | Added +71% | |
| 0.06% | $18.50 | −44.2% | $10.33 | No change | |
| 0.06% | $2.20 | −36.3% | $1.40 | New | |
| 0.06% | $12.74 | +10.8% | $14.12 | No change | |
| 0.05% | $10.14 | +25.2% | $12.70 | No change | |
| 0.05% | $26.21 | −1.3% | $25.88 | New | |
| 0.05% | $28.86 | −72.2% | $8.01 | No change | |
| 0.05% | $6.39 | −60.9% | $2.50 | No change | |
Abivax Sa-AdrABVX | 0.03% | $133.26 | −33.2% | $89.05 | New |
| 0.03% | $15.64 | −14.1% | $13.43 | Reduced −80% | |
| 0.02% | $42.00 | −14.9% | $35.74 | No change | |
| 0.02% | $84.50 | −28.1% | $60.77 | No change | |
| 0.02% | $13.25 | −67.9% | $4.26 | No change | |
Exagen Inc.XGN | 0.01% | $11.02 | −25.8% | $8.17 | Reduced −51% |
Rocket Pharmaceuticals In-2777313F114 | 0.00% | $0.11 | — | — | No change |
Rod Wong's buys and sells
| Company | Action | Shares change | Value now |
|---|---|---|---|
| Reduced −48% | −1,405,826 | $158.3M | |
| New | +1,062,072 | $133.5M | |
| Added +7.1% | +203,078 | $288.6M | |
Alkermes PLCALKS | Reduced −32% | −2,202,409 | $134M |
| Sold out | −1,125,000 | — | |
Insmed Inc.INSM | Added +2.3% | +70,000 | $310.4M |
Zai Lab Ltd-AdrZLAB | Added +77% | +2,400,196 | $193.6M |
| Added +405% | +401,003 | $89.8M | |
Natera Inc.NTRA | Added +0.0% | +99 | $438.2M |
| New | +444,000 | $60.4M | |
| Added +5.3% | +455,430 | $194M | |
| New | +856,501 | $44.6M | |
| Reduced −6.2% | −204,352 | $126.1M | |
| Added +0.6% | +36,862 | $318.1M | |
Radnet Inc.RDNT | Added +16% | +372,762 | $153.1M |
Soleno Therapeutics Inc.834203309 | New | +424,408 | $35.6M |
| New | +741,090 | $35M | |
Merus NVN5749R100 | Reduced −4.0% | −168,840 | $210.4M |
| Added +33% | +6,233,718 | $57.8M | |
Uniqure NVQURE | Added +21% | +892,803 | $71.9M |
Arvinas Inc.ARVN | Sold out | −3,334,308 | — |
| Added +18% | +709,101 | $62.3M | |
Centessa Pharmaceuticals-Adr152309100 | Added +2960% | +1,479,836 | $20.1M |
Glaukos Corp.GKOS | Sold out | −190,000 | — |
Avidity Biosciences Inc.05370A108 | Added +10.0% | +871,919 | $273.2M |
| New | +1,449,273 | $14.5M | |
Rapt Therapeutics Inc.75382E109 | Sold out | −11,764,000 | — |
| Added +0.1% | +296 | $233.6M | |
Crinetics Pharmaceuticals In22663K107 | New | +467,000 | $13.4M |
| Added +1.2% | +99,900 | $22.3M | |
| Reduced −71% | −2,912,297 | $5M | |
| New | +1,470,499 | $11.8M | |
| Added +0.1% | +783 | $221.6M | |
| Sold out | −438,659 | — | |
Akero Therapeutics Inc.00973Y108 | Reduced −26% | −1,941,779 | $292.3M |
Verastem Inc.VSTM | Added +0.1% | +6,140 | $17.6M |
| New | +3,461,500 | $7.9M | |
| Reduced −0.0% | −679 | $48M | |
| Added +48% | +2,683,761 | $23M | |
GH Research PLCGHRS | Added +0.7% | +40,688 | $67.5M |
Exagen Inc.XGN | Added +12% | +185,000 | $11.8M |
Immatics NVIMTX | Added +0.9% | +60,642 | $37.5M |
| Added +0.0% | +244 | $110.4M | |
Neurogene Inc.NGNE | Added +1.0% | +13,800 | $20.4M |
| Added +20% | +106,000 | $46.4M | |
| New | +200,000 | $3.7M | |
| Added +3.5% | +263,288 | $378.3M | |
Bioage Labs Inc.BIOA | Sold out | −786,353 | — |
Allurion Technologies-2802008G201 | Added +142% | +1,492,540 | $6.2M |
Immunic Inc.4525EP101 | New | +402,107 | $280.5K |
Rod Wong's portfolio by sector
Share of the stock portfolio at Q2 2026.
| Sector | Share |
|---|---|
| Health Care | 99% |
| Technology | 0.7% |
| Other | 0.2% |
Portfolio performance: Rod Wong vs. benchmarks
Your result if you had bought each reported portfolio on the day it was made public and held it until the next report, against the S&P 500 and Nasdaq-100.
- You, copying after each 13F filing – estimated value
- S&P 500
- Nasdaq-100
| Total return | Per year | |
|---|---|---|
| You, copying after each 13F filing – estimated value | −4.1% | −0.8% |
| S&P 500 | +89.0% | +13.6% |
| Nasdaq-100 | +113.3% | +16.4% |
Prices were available for 66% of the portfolio value on average; the rest is left out of the return.
Rod Wong's most traded stocks
Quarters with a buy or a sell, all reports since Q4 2014.
| Company | Quarters bought | Quarters sold |
|---|---|---|
| 21 | 7 | |
Regenxbio Inc.RGNX | 19 | 9 |
| 17 | 11 | |
| 23 | 4 | |
| 15 | 11 | |
| 16 | 10 | |
| 18 | 7 | |
| 20 | 5 | |
| 16 | 8 | |
Natera Inc.NTRA | 16 | 6 |
| 15 | 7 | |
Argenx SE - ADRARGX | 20 | 2 |
Uniqure NVQURE | 15 | 6 |
Vericel Corp.VCEL | 12 | 8 |
Exagen Inc.XGN | 13 | 6 |